- Price
- $270.22
- Day
- +1.10%
- Mkt Cap
- $651.20B
- 52W Range
- $173.33 – $281.07
- Volume
- 6.38M
- Beta
- 0.23
Find a company by name or ticker and open its page
Snapshot of fundamentals, performance, and 5D scores.
Business fundamentals and company information
Recent price action and historical returns
How the business makes money, by product and geography
Five lenses on the stock. Click any card to dive deeper.
How to read these dimensions
The five dimensions are independent lenses on a company, not a single combined score. Read them together rather than in isolation: where one dimension scores differently from the others is often the most useful place to focus your own research. Each score is built from rules and weights you can adjust, so treat them as a transparent starting point for your analysis, not a recommendation to buy or sell.
Recent news headlines and analyst price-target moves
Is AbbVie the Best Dividend King to Buy in September?
It is certainly a good Dividend King to buy in September.
HORAN Wealth LLC Decreases Stock Position in Johnson & Johnson $JNJ
HORAN Wealth LLC trimmed its position in shares of Johnson and Johnson (NYSE: JNJ) by 51.5% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 23,953 shares of the company's stock after selling 25,391 shares during the period.
Johnson & Johnson $JNJ Shares Sold by HighTower Advisors LLC
HighTower Advisors LLC decreased its stake in shares of Johnson and Johnson (NYSE: JNJ) by 5.6% during the undefined quarter, according to its most recent Form 13F filing with the SEC. The fund owned 9,892,767 shares of the company's stock after selling 591,434 shares during the period. Johnson and Johnson comprises about 2.4%
Tucker Asset Management LLC Purchases 3,178 Shares of Johnson & Johnson $JNJ
Tucker Asset Management LLC raised its position in shares of Johnson and Johnson (NYSE: JNJ) by 173.4% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 5,011 shares of the company's stock after purchasing an additional 3,178 shares during the quarter.
Monthly Paydays vs. Compound Growth: Why JNJ Beats O for Long-Term Retirees
Realty Income pays you every month while Johnson and Johnson barely clears 2% yield, yet one of these retirement staples is quietly demolishing the other where it counts most for a 20-year income plan.